Vonoprazan: MarKed Competition for PPIs?
- PMID: 27074922
- PMCID: PMC4920708
- DOI: 10.1007/s10620-016-4164-8
Vonoprazan: MarKed Competition for PPIs?
Comment on
-
Radiographic Localization Study of a Novel Potassium-Competitive Acid Blocker, Vonoprazan, in the Rat Gastric Mucosa.Dig Dis Sci. 2016 Jul;61(7):1888-94. doi: 10.1007/s10620-016-4100-y. Epub 2016 Mar 9. Dig Dis Sci. 2016. PMID: 26961787
References
-
- Lindberg P, Brandstrom A, Wallmark B, Mattsson H, Rikner L, Hoffmann KJ. Omeprazole: the first proton pump inhibitor. Med Res Rev. 1990;10:1–54. - PubMed
-
- Gedda K, Scott D, Besancon M, Lorentzon P, Sachs G. Turnover of the gastric H+,K+-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion. Gastroenterology. 1995;109:1134–1141. - PubMed
-
- Cederberg C, Lind T, Rohss K, Olbe L. Comparison of once-daily intravenous and oral omeprazole on pentagastrin-stimulated acid secretion in duodenal ulcer patients. Digestion. 1992;53:171–178. - PubMed
-
- Sakai T, Aoyama N, Kita T, et al. CYP2C19 genotype and pharmacokinetics of three proton pump inhibitors in healthy subjects. Pharm Res. 2001;18:721–727. - PubMed
-
- Furuta T, Shirai N, Ohashi K, Ishizaki T. Therapeutic impact of CYP2C19 pharmacogenetics on proton pump inhibitor-based eradication therapy for Helicobacter pylori. Methods Find Exp Clin Pharmacol. 2003;25:131–143. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
